SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat is gaining attention, with community members highlighting its recent launch on Phantom Wallet and potential for significant growth. The conversation revolves around 'moon' and 'rocket' references suggesting possible rapid price appreciation. Some users are pointing out potential scam risks.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

GBTC is trending as Bitcoin flirts with all-time highs, driving discussion about potential breakouts and future price targets. Community members are closely watching technical indicators and whale activity, anticipating a continued uptrend. Broader market factors, like potential shifts from gold to Bitcoin and the impact of government policies, are also being considered.

Moo Deng

MOODENG is trending as traders discuss recent price volatility and potential for a breakout. Community members are debating entry points, with some pointing to technical analysis patterns, while others express skepticism, citing its meme coin status and past performance. The coin's listing on Robinhood and upcoming birthday are also being mentioned as potential catalysts.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending following FDA approval of their leukemia drug, Revuforj, though a boxed warning regarding potentially fatal side effects tempers initial enthusiasm. The community is debating the impact of the safety label, comparing it to competitor Kura Oncology's profile, and weighing whether the market is overreacting given the drug's efficacy and the unmet need it addresses. Some believe the dip is a buying opportunity, while others worry about potential risks and side effects.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid discussions about a potential recall of specific lots and the impact on revenue, with community members analyzing the company's response and comparing it to similar situations with competitors. Some traders are interpreting recent stock sales by the CEO, alongside an FDA safety notice, while others suggest potential manufacturing issues. Despite concerns, many community members express confidence in the company's long-term growth and potential for a buyback.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending as investors discuss dividend payouts, NAV erosion, and overall profitability; some express concern over the fund's long-term viability. Community members are weighing strategies like reinvesting dividends versus taking profits, with some considering alternative high-yield ETFs.  Broader discussions include the impact of market volatility and potential reverse splits.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending as investors anticipate potential new contracts following its Gen AI Summit, where over 300 AI executives were in attendance. The community speculates about a possible TikTok deal and expansion into government contracts, driving institutional interest. Bullish sentiment is fueled by analysts increasing price targets, though some caution against excessive speculation and highlight the company's AI-driven growth amid rising competition.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

Inhibrx ($INBX) is trending due to positive updates on its INBRX-101 drug for AATD, specifically regarding a functional alpha-1 antitrypsin serum levels endpoint, leading to speculation about accelerated FDA approval; the community is actively discussing its potential and analyst target price increase. Some traders are noting its low float and potential for a short squeeze, while others are wary of a possible upcoming offering.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the stock price continues to drop post FDA approval, leading to discussions around management, dilution, and future prospects. The community is debating whether the current price represents a buying opportunity or reflects deeper issues with the company's leadership and commercialization strategy. Some traders are noting potential short squeeze setups due to high short interest.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to advancements in quantum computing, including a partnership leveraging AMD chips for error correction, which has driven its largest single-day stock surge since January; community discussions highlight IBM's potential leadership in quantum and AI. While reactions to recent earnings have been mixed, some see the stock as undervalued, with potential upside driven by its hybrid cloud and AI initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gorilla Technology Group Inc. (GRRR) stock was in the spotlight in Tuesday’s premarket session as retail investors expressed confidence about the company’s recent contract wins and its operations in AI infrastructure and intelligence.&nbsp;The stock traded over 5% higher on Tuesday morning and was among the top five trending equity tickers on Stocktwits. Gorilla stock also experienced a 372% surge in user message count over the last 24 hours.&nbsp;A bullish Stocktwits user stated that the stock should be $40 or more at this time. “Many other lesser stocks are trading much higher than that. Unbelievable! Way way undervalued. Let it run!”<stembedurl>https://stocktwits.com/ChiefStockTraderJr/message/631201379</stembedurl>Another user highlighted the company’s recent $1.4 billion data center deal.&nbsp;<stembedurl>https://stocktwits.com/mikesterz7/message/631273798</stembedurl>The company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/gorilla-technology-stock-soared-nearly-10-percent-today-here-is-an-update/chDGrgsRd6j">disclosed</a> on September 17 that it had finalized a binding three-year deal worth $1.4 billion with infrastructure firm Freyr Singapore. The initial phase of the project, known as “Phase One,” carries a value of $300 million and is scheduled to launch in the fourth quarter of 2025. Under the provisions of the agreement, Gorilla will be the chief operator and AI infrastructure provider, responsible for implementing advanced computing systems across Indonesia, Malaysia, and Thailand.&nbsp;Additionally, the company landed another major government deal in the Asia-Pacific region on September 8. The one-year contract, worth tens of millions of dollars, will support AI-driven smart policing through GPU-as-a-Service.In a recent fireside chat, Gorilla’s Chairman and CEO, Jayesh Chandan, said the company is a full-stack builder and operator of sovereign AI infrastructure. “Today, more than 80% of our revenue is actually government and public agencies,” said Chandan.&nbsp;Gorilla Technology stock has gained over 14% in 2025 and over 406% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/paul-tudor-jones-sees-market-blow-off-phase-ahead/ch6PPr0R3WL">Paul Tudor Jones Sees Market ‘Blow-Off’ Phase Ahead, But Expects Further Rally On Pure FOMO: ‘All Ingredients Are In Place’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Gorilla Technology logo is seen displayed on a smartphone screen. 

GRRR Shares Rally Over 4% Pre-Market, Retail Says Stock Should Be Trading Over $40: ‘Unbelievable! Way, Way Undervalued’

Gorilla Technology stock experienced a 372% surge in user message count on Stocktwits over the last 24 hours.

Equity

Gorilla Technology stock experienced a 372% surge in user message count on Stocktwits over the last 24 hours.


Baidu's AI Buzz vs. Revenue Reality: Time for Investors to Cash Out?

BIDU's AI hype can't mask the reality of -45% operating income, negative cash flow, and declining core business, making this stock a clear sell.

iQIYI sees surge in viewership during Chinese New Year: users favor classic IPs, long and short content, and strong interaction

iQIYI sees surge in viewership during Chinese New Year: users favor classic IPs, long and short content, and strong interaction iQIYI sees surge in viewership during Chinese New Year: users favor...

iQIYI upgrades Diamond VIP benefits, enhancing unmatched membership experience

iQIYI upgrades Diamond VIP benefits, enhancing unmatched membership experience iQIYI upgrades Diamond VIP benefits, enhancing unmatched membership experience PR Newswire BEIJING, Jan. 24, 2025...

iQIYI's hit drama 'Mysterious Lotus Casebook' showcases diversified development model, another case proving the Value of IP

iQIYI's hit drama 'Mysterious Lotus Casebook' showcases diversified development model, another case proving the Value of IP iQIYI's hit drama 'Mysterious Lotus Casebook' showcases diversified...

iQIYI leads genre-specific storytelling with the return of its trend-setting 'Light On Theater,' featuring seven new suspense dramas

iQIYI leads genre-specific storytelling with the return of its trend-setting 'Light On Theater,' featuring seven new suspense dramas iQIYI leads genre-specific storytelling with the return of its...

iQIYI Celebrates Content Excellence and Social Impact at Scream Night 2024

iQIYI Celebrates Content Excellence and Social Impact at Scream Night 2024 iQIYI Celebrates Content Excellence and Social Impact at Scream Night 2024 PR Newswire BEIJING, Dec. 11, 2024 BEIJING, Dec...

iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users

iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users PR Newswire BEIJING, Dec...

iQIYI Introduces Standard VIP Family and Friends Membership to Enhance Subscription Flexibility and Premium Content Access

iQIYI Introduces Standard VIP Family and Friends Membership to Enhance Subscription Flexibility and Premium Content Access iQIYI Introduces Standard VIP Family and Friends Membership to Enhance...

iQIYI's 'Love On Theater' Premieres 'Fangs of Fortune,' Setting Benchmark for C-Drama Virtual Production

iQIYI's 'Love On Theater' Premieres 'Fangs of Fortune,' Setting Benchmark for C-Drama Virtual Production iQIYI's 'Love On Theater' Premieres 'Fangs of Fortune,' Setting Benchmark for C-Drama Virtual...

iQIYI, Inc. provides online entertainment services. It attracts a massive user base with tremendous user engagement, and has developed a diversified monetization model including membership services, online advertising services, content distribution, online games, live broadcasting, IP licensing, talent agency and online literature. The firm distinguishes itself in the online entertainment industry by its technology platform powered by advanced AI, big data analytics and other core proprietary technologies. The company was founded by Yu Gong on November 27, 2009 and is headquartered in Haidan District, China.

iQIYI Inc - ADR

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

IQ
iQIYI Inc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IQ News

IQiQIYI Inc - ADR